GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Take Solutions Ltd (BOM:532890) » Definitions » YoY EBITDA Growth

Take Solutions (BOM:532890) YoY EBITDA Growth : 542.53% (As of Dec. 2024)


View and export this data going back to 2007. Start your Free Trial

What is Take Solutions YoY EBITDA Growth?

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months. Take Solutions's YoY EBITDA Growth for the quarter that ended in Dec. 2024 was 542.53%.

Take Solutions's EBITDA per Share for the three months ended in Dec. 2024 was ₹0.39.

Take Solutions YoY EBITDA Growth Historical Data

The historical data trend for Take Solutions's YoY EBITDA Growth can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Take Solutions YoY EBITDA Growth Chart

Take Solutions Annual Data
Trend Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
YoY EBITDA Growth
Get a 7-Day Free Trial Premium Member Only Premium Member Only -51.79 -258.13 115.28 -147.49 -392.53

Take Solutions Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
YoY EBITDA Growth Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 60.27 -5,942.61 1.91 9.57 542.53

Take Solutions YoY EBITDA Growth Calculation

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months.

Take Solutions's YoY EBITDA Growth for the fiscal year that ended in Mar. 2024 is calculated as:

YoY EBITDA Growth (A: Mar. 2024 )
=(EBITDA per Share (A: Mar. 2024 )-EBITDA per Share (A: Mar. 2023 ))/ | EBITDA per Share (A: Mar. 2023 ) |
=(-7.186--1.459)/ | -1.459 |
=-392.53 %

Take Solutions's YoY EBITDA Growth for the quarter that ended in Dec. 2024 is calculated as:

YoY EBITDA Growth (Q: Dec. 2024 )
=(EBITDA per Share (Q: Dec. 2024 )-EBITDA per Share (Q: Dec. 2023 )) / | EBITDA per Share (Q: Dec. 2023 )) |
=(0.385--0.087)/ | -0.087 |
=542.53 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Take Solutions YoY EBITDA Growth Related Terms

Thank you for viewing the detailed overview of Take Solutions's YoY EBITDA Growth provided by GuruFocus.com. Please click on the following links to see related term pages.

Take Solutions Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Take Solutions Ltd (BOM:532890) » Definitions » YoY EBITDA Growth
Comparable Companies
BOM:542910 BOM:511509 BOM:526139 BOM:524238 BOM:514336 BOM:506365 BOM:539206 BOM:531207 BOM:524717 BOM:500259 VRTX ASX:CSL REGN XKRX:207940 XBRU:ARGX ALNY XBRU:UCB ONC BNTX XKRX:068270
Traded in Other Exchanges
TAKE:India
Address
No.56, Dr. Radhakrishnan Salai, 4th Floor, Ragas Building, Mylapore, Chennai, TN, IND, 600004
Website
https://www.takesolutions.com
Take Solutions Ltd is a technology-driven clinical research organization supporting pharma, biotech, and devices companies. It offers a combination of full-service Clinical Research, Generics Development, Data Sciences, Regulatory Affairs, and Pharmacovigilance and Safety services. The company operates in a single segment; Life Sciences and Support Services.

Take Solutions Headlines

No Headlines